Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657 · clinicaltrials.gov ↗

COMPLETED

Status

1723

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)

Interventions

DRUG: Interferon beta-1b (Betaseron, BAY86-5046)

Sponsor

Bayer